82611-57-2

Basic information

• Product Name: 2-(benzyloxycarbonyl)-3-(4-bromophenyl)propanoic acid
• Synonyms: 2-(benzyloxycarbonyl)-3-(4-bromophenyl)propanoic acid
• CAS NO: 82611-57-2
• Molecular Weight: 0
• Mol File: 82611-57-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(benzyloxycarbonyl)-3-(4-bromophenyl)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(benzyloxycarbonyl)-3-(4-bromophenyl)propanoic acid(82611-57-2)
• EPA Substance Registry System: 2-(benzyloxycarbonyl)-3-(4-bromophenyl)propanoic acid(82611-57-2)

Safety Data

• Hazardous Substances Data: 82611-57-2(Hazardous Substances Data)

Usage

Molecular structure

Contains a benzyloxycarbonyl group and a 4-bromophenyl group attached to a propanoic acid molecule.

Derivative

Is a derivative of propanoic acid.

Usage

Often used in organic synthesis and medicinal chemistry.

Protecting group

Benzyloxycarbonyl group is commonly used as a protecting group for amines in organic synthesis.

Pharmaceutical and agrochemical compounds

4-bromophenyl group is often found in pharmaceutical compounds and agrochemicals.

Potential applications

Could have potential applications in the development of new drugs or other bioactive molecules due to its structure and reactivity.

Upstream product

• 10466-61-2 (2S)-amino-4-methylpentanamide hydrochloride 
• 14091-15-7 p-bromo-DL-phenylalanine 
• 501-53-1 benzyl chloroformate 
• 187028-22-4 Z-DL-Phe(4Br)-OCH₂CF₃ 
• 141971-13-3 Z-DL-Phe(4Br)OMe 

Downstream Products

• 141971-13-3 Z-DL-Phe(4Br)OMe 
• 187028-22-4 Z-DL-Phe(4Br)-OCH₂CF₃ 
• 1021733-85-6 benzyl {1-(4-bromobenzyl)-2-[(2-hydroxy-4,4-dimethylhexyl)amino]-2-oxoethyl}carbamate 

Relevant articles and documents

SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS

Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

α-chymotrypsin-catalysed peptide synthesis via the kinetically controlled approach using activated esters as acyl donors in organic solvents with low water content: Incorporation of non-protein amino acids into peptides

The α-chymotrypsin-catalyzed peptide synthesis via the kinetically controlled approach using activated esters as acyl donors in orgnanic solvents with low water content was presented. The methyl esters of N-Z derivatives of racemic non-protein amino acids were chosen as carboxy components. They allowed the peptide-bond formation and optical resolution simultaneously to yield homochiral peptides. This method is useful for the incorporation of non-protein amino acids into peptides.